Maraviroc
Active substance: maraviroc
TABLET, FILM COATED · MARAVIROC 300 mg/1
United StatesActive
Marketing holder: Camber Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- MARAVIROC · 300 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 2 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-8870-7794-a5b0-12644dc3769a,01a120c5-a107-730c-919c-03280b2f1148;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2b46-7333-9f00-cb1da2c779a5,01a1208c-2d62-731e-ac89-d98e90136aa1,01a1208c-657e-701b-8d20-5086369b939a,01a1208c-bb72-7c26-9d3e-6a7c2bcd252d,01a1208d-05ef-7d4e-873a-c0d2267e8aac;count=20 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 31722-580
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 31722-580 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 31722-580 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 31722-580 · Verified 2026-10-09 · open in source